July, 2005 edited excerpts from: Complex herbs-complete medicines, eclectic medical publications, Sandy, OR, 2004

Journal of Herbal Pharmacotherapy

Volumn 5, Issue 4, 2006, Pages 63-69

  Brinker, Francis ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID DERIVATIVE; HERBACEOUS AGENT; HYPERFORIN; HYPERICIN; HYPERICUM PERFORATUM EXTRACT; MIG 99; PARTHENOLIDE; PLACEBO; PLANT MEDICINAL PRODUCT; SABAL EXTRACT; SITOSTEROL; TANACETUM PARTHENIUM EXTRACT; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL TRIAL; DEPRESSION; DRUG ISOLATION; DRUG POTENCY; DRUG SYNTHESIS; HERBAL MEDICINE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MEDICAL LITERATURE; MIGRAINE; NONHUMAN; PHYTOCHEMISTRY; PRIORITY JOURNAL; PUBLICATION; STANDARDIZATION;

HUMANS; PHYTOTHERAPY; PLANT EXTRACTS; QUALITY CONTROL;

EID: 33746516139     PISSN: 15228940     EISSN: 15229106     Source Type: Journal    
DOI: 10.1300/J157v05n04_07     Document Type: Article

References (13)

1. Lloyd JU. Standards of excellence, Ecl. Med, J., 69:683-5, 1909.
2. Johnson ES, Kadam NP, Hylands DM, Hylands PJ. Efficacy of feverfew as prophylactic treatment of migraine. Br. Med. J., 291:569-73, 1985.
3. Murphy JJ, Heptinstall S, Mitchell JR. Randomised double-blind placebo-controlled trial of feverfew in migraine prevention. Lancet, pp. 189-92, July 23, 1988.
4. Palevitch D, Earon G, Carasso R. Feverfew (Tanacetum parthenium) as a prophylactic treatment for migraine: A double-blind placebo-controlled study. Phytother. Res., 11:508-11, 1997.
5. De Weerdt CJ, Bootsma HPR, Hendriks H. Herbal medicines in migraine prevention. Phytomed., 3:225-30, 1996.
6. Awang DVC. Prescribing therapeutic feverfew (Tanacetum parthenium (L.) Schultz Bip., syn. Chrysanthemum parthenium (L.) Bernh.). Intergrat. Med., 1(1): 11-13, 1998.
7. Pfaffenrath V, Diener HC, Fischer M, Friede M, Henneicke-von Zepelin HH. The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis-a double-blind, multicentre, randomized placebo-controlled dose-response study. Cephalg., 22:523-32, 2002.
8. Murray MT. Understanding the benefits of standardized botanical extracts. Am. J. Nat. Med., 3(8):6-12, 1996.
9. Bone K. Standardized extracts neither poison nor panacea. HerbalGram, 53: 50-5, 2001.
10. Patterson E. Standardized extracts: Herbal medicine of the future? Herb Market Review, pp. 37-8, 1996.
11. Constantine GH, Karchesy J. Variations in hypericin concentrations in Hypericum perforatum L. and commercial products. Pharmaceut. Biol., 36(5):365-7, 1998.
12. Liu FF, Ang CY, Heinze TM, Rankin JD, Beger RD, Freeman JP, Lay JO Jr. Evaluation of major active components in St. John's wort dietary supplements by high-peformance liquid chromatography with photodiode array detection and electrospray mass spectrometric confirmation. J. Chromatogr., 888:85-92, 2000.
13. Ganzera M, Zhao J, Khan IA. Hypericum perforatum-Chemical profiling and quantitative results of St. John's wort products by an improved high-performance liquid chromatography method. J. Pharm. Sci., 91(3):623-30, 2002.